Avanos MedicalAVNS +0.08%62 PB Ratio is 1.49 as of Jun. 24, 2026, which is 21% above its 10-year median of 1.23. GuruFocus rates AVNS with a GF Score™ of 62/100 and a GF Value™ of $19.43 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Avanos Medical ranks better than 64.55% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-24), Avanos Medical's share price is $24.95. Avanos Medical's Book Value per Share for the quarter that ended in Mar. 2026 was $16.76. Hence, Avanos Medical's PB Ratio of today is 1.49.
Warning Sign:
Avanos Medical Inc stock PB Ratio (=1.49) is close to 5-year high of 1.49.
The historical rank and industry rank for Avanos Medical's PB Ratio or its related term are showing as below:
AVNS'
s PB Ratio Range Over the Past 10 Years
Min: 0.59 Med: 1.23 Max: 2.66
Current: 1.49
During the past 13 years, Avanos Medical's highest PB Ratio was 2.66. The lowest was 0.59. And the median was 1.23.
AVNS's PB Ratio is ranked better than 64.55% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs AVNS: 1.49
During the past 12 months, Avanos Medical's average Book Value Per Share Growth Rate was -7.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -15.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -9.30% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -2.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Avanos Medical was 6.50% per year. The lowest was -20.00% per year. And the median was -1.20% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Avanos Medical PB Ratio Related Terms
Avanos Medical PB Ratio Historical Data
* Premium members only.
The historical data trend for Avanos Medical's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Avanos Medical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avanos Medical PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avanos Medical's PB Ratio distribution charts can be found below:
* The bar in red indicates where Avanos Medical's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Avanos Medical's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Avanos Medical (AVNS) has a PB Ratio of 1.49 as of Jun. 24, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Avanos Medical and its competitors. This is 21% above median its historical median of 1.23. Over the past decade, Avanos Medical's PB Ratio has ranged from 0.59 to 2.66. According to the industry distribution chart, Avanos Medical ranks #279 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 35.5%.
Is Avanos Medical's PB Ratio too high?
Avanos Medical's current PB Ratio of 1.49 is 21% above median its 10-year median of 1.23. Over the past 10 years, this metric has ranged from a low of 0.59 to a high of 2.66. The Medical Devices & Instruments industry median PB Ratio is 2.04. Avanos Medical's value of 1.49 is 27% below this industry median. Based on the distribution chart, Avanos Medical ranks #279 out of 787 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Avanos Medical has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avanos Medical's PB Ratio compare to IRMD and TNDM?
According to the Medical Devices & Instruments industry distribution chart, Avanos Medical ranks #279 out of 787 companies for PB Ratio. This puts Avanos Medical in the upper half of its industry. The industry median PB Ratio is 2.04. Avanos Medical's value of 1.49 is 27% below this benchmark. Historically, Avanos Medical's own PB Ratio has ranged from 0.59 to 2.66 over the past decade. While the company's 10-year median is 1.23 vs. the industry median of 2.04, Avanos Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.04, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avanos Medical's current PB Ratio of 1.49 is 27% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Avanos Medical and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avanos Medical's current PB Ratio is 1.49, which is 21% above median its own 10-year median of 1.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avanos Medical stock overvalued right now?
Based on GuruFocus' analysis, Avanos Medical (AVNS) is currently considered Modestly Overvalued. The stock's GF Value™ is $19.43, compared to a current price of $24.95 — trading 28.4% above its estimated fair value. The current PB Ratio is 1.49, which is 21% above median its 10-year median of 1.23 and 27% below the Medical Devices & Instruments industry median of 2.04. Avanos Medical's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Avanos Medical (AVNS), the current PB Ratio is 1.49 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avanos Medical (AVNS) Overvalued in 2026?
Based on GuruFocus' analysis, Avanos Medical stock appears to be overvalued.
The current stock price of $24.95 is trading 28.4% above its estimated GF Value™ of $19.43.
GuruFocus considers Avanos Medical to be Modestly Overvalued.
Key valuation signals for AVNS:
PB Ratio: 1.49 (21% above median its 10-year median of 1.23)
GF Value™: $19.43 vs. price of $24.95 (28.4% above fair value)
Industry Position: 27% below the Medical Devices & Instruments median (#279 of 787)
No single metric tells the full story. See the AVNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
62GF Score
Get the complete analysis for AVNS
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVNS has been successfully added to your 
